Company Presentation • 07 Nov 2024 21:00
Company Presentation • 08 Aug 2024 20:00
Company Presentation • 07 Jun 2024 20:00
Company Presentation • 02 May 2024 20:00
Company Presentation • 28 Feb 2024 21:00
ENTITY
Geron Corp (GERN US)
Geron Corp (GERN US)
3
Analysis
Health Care • United States
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
more
x